Kilpest India is currently trading at Rs. 172.50, up by 2.50 points or 1.47% from its previous closing of Rs. 170.00 on the BSE.
The scrip opened at Rs. 176.70 and has touched a high and low of Rs. 176.70 and Rs. 162.25 respectively. So far 1462 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 178.75 on 30-Apr-2018 and a 52 week low of Rs. 33.50 on 07-Jun-2017.
Last one week high and low of the scrip stood at Rs. 178.75 and Rs. 160.00 respectively. The current market cap of the company is Rs. 110.54 crore.
The promoters holding in the company stood at 43.42%, while Non-Institutions held at 56.58%.
Kilpest India’s Subsidiary Company -- 3B Blackbio Biotech (I) Bhopal has been declared as the Winner of National Award of Rs 15 lakh to be given to MSMEs for the year 2018, for ‘Successfully Commercialized A Product Based on Indigenous Technology’.
The award has been conferred by Technology Development Board, Department of Science & Technology, Government of India. The award shall be given by President of India on May 11, 2018.
3B Blackbio Biotech (I) Bhopal has successfully commercialized the indigenous Molecular Diagnostic Kit for detection of Fusion gene BCR-ABL1, which is mainly responsible for chronic myeloid leukemia (CML). This is the flagship product of the company and has been appreciated very well across various prestigious Government/Private diagnostic laboratories of the country.
Kilpest India is one of India’s leading Agri based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising Crop Protection Products and Public Health Products, Bio products, Micro-Nutrients and Mix fertilizers.